Memphasys Ltd - ESG Rating & Company Profile powered by AI
The analysis of Memphasys Ltd uses intelligence from across the internet and also from available disclosures by Memphasys Ltd. This SDG assessment for Memphasys Ltd indicates the company's reporting of the United Nations SDGs. Scroll down to the end of the page for potential risks for Memphasys Ltd based on industry, location and size.
Memphasys Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Memphasys Ltd | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Memphasys Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Memphasys Ltd disclose current and historical energy intensity?
Does Memphasys Ltd report the average age of the workforce?
Does Memphasys Ltd reference operational or capital allocation in relation to climate change?
Does Memphasys Ltd disclose its ethnicity pay gap?
Does Memphasys Ltd disclose cybersecurity risks?
Does Memphasys Ltd offer flexible work?
Does Memphasys Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Memphasys Ltd disclose the number of employees in R&D functions?
Does Memphasys Ltd conduct supply chain audits?
Does Memphasys Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Memphasys Ltd conduct 360 degree staff reviews?
Does Memphasys Ltd disclose the individual responsible for D&I?
Does Memphasys Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Memphasys Ltd disclose current and / or historical scope 2 emissions?
Does Memphasys Ltd disclose water use targets?
Does Memphasys Ltd have careers partnerships with academic institutions?
Did Memphasys Ltd have a product recall in the last two years?
Does Memphasys Ltd disclose incidents of discrimination?
Does Memphasys Ltd allow for Work Councils/Collective Agreements to be formed?
Has Memphasys Ltd issued a profit warning in the past 24 months?
Does Memphasys Ltd disclose parental leave metrics?
Does Memphasys Ltd disclose climate scenario or pathway analysis?
Does Memphasys Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Memphasys Ltd disclose the pay ratio of women to men?
Does Memphasys Ltd support suppliers with sustainability related research and development?
Does Memphasys Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Memphasys Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Memphasys Ltd involved in embryonic stem cell research?
Does Memphasys Ltd disclose GHG and Air Emissions intensity?
Does Memphasys Ltd disclose its waste policy?
Does Memphasys Ltd report according to TCFD requirements?
Does Memphasys Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Memphasys Ltd disclose energy use targets?
Does Memphasys Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Memphasys Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Memphasys Ltd
These potential risks are based on the size, segment and geographies of the company.
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.